Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
226,664,950
-
Total 13F shares
-
15,000
-
Share change
-
0
-
Total reported value
-
$47,550
-
Price per share
-
$3.17
-
Number of holders
-
1
Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) as of Q4 2023
As of 31 Dec 2023,
Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
15,000 shares.
The largest 10 holders included
VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, NORTHERN TRUST CORP, 683 Capital Management, LLC, and Qube Research & Technologies Ltd.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.